HRHenricus G Ruhe

Henricus G Ruhe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Henricus G Ruhe has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Roel J. T. Mocking

    University of Amsterdam

    2 shared publications
  • A. Aleman

    University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands; Department of Psychology, University of Groningen, Groningen, the Netherlands

    1 shared publication
  • Aart H Schene

    Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands

    1 shared publication
  • Aart H. Schene

    Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    1 shared publication
  • Annemieke Horikx

    Royal Dutch Pharmacists Association, The Hague, Netherlands

    1 shared publication
  • B.W.J.H. Penninx

    Department of Psychiatry, Amsterdam UMC, Locatie VUmc, VU University Amsterdam, Amsterdam, the Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Impaired reward-related learning signals in remitted unmedicated patients with recurrent depression

    by Hanneke Geugies, Roel J T Mocking, Caroline A Figueroa, Paul F C Groot, Jan-Bernard C Marsman, Michelle N Servaas, J Douglas Steele, Aart H Schene, Henricus G Ruhé

    One of the core symptoms of major depressive disorder is anhedonia, an inability to experience pleasure. In patients with major depressive disorder, a dysfunctional reward-system may exist, with blunted temporal difference reward-related learning signals in the ventral striatum and increased temporal difference-related (dopaminergic) activation in the ventral tegmental area. Anhedonia often remains as residual symptom during remission; however, it remains largely unknown whether the abovementioned reward systems are still dysfunctional when patients are in remission. We used a Pavlovian classical conditioning functional MRI task to explore the relationship between anhedonia and the temporal difference-related response of the ventral tegmental area and ventral striatum in medication-free remitted recurrent depression patients (n = 36) versus healthy control subjects (n = 27). Computational modelling was used to obtain the expected temporal difference errors during this task. Patients, compared to healthy controls, showed significantly increased temporal difference reward learning activation in the ventral tegmental area (PFWE,SVC = 0.028). No differences were observed between groups for ventral striatum activity. A group × anhedonia interaction [t(57) = −2.29, P = 0.026] indicated that in patients, higher anhedonia was associated with lower temporal difference activation in the ventral tegmental area, while in healthy controls higher anhedonia was associated with higher ventral tegmental area activation. These findings suggest impaired reward-related learning signals in the ventral tegmental area during remission in patients with depression. This merits further investigation to identify impaired reward-related learning as an endophenotype for recurrent depression. Moreover, the inverse association between reinforcement learning and anhedonia in patients implies an additional disturbing influence of anhedonia on reward-related learning or vice versa, suggesting that the level of anhedonia should be considered in behavioural treatments.


  • Tapering of SSRI treatment to mitigate withdrawal symptoms

    by Henricus G Ruhe, Annemieke Horikx, Mariëlle J P van Avendonk, Bart F Groeneweg, Hèlen Woutersen-Koch


  • Open Access

    Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder

    by Caroline A. Figueroa, Joana Cabral, Roel J. T. Mocking, Kristina M. Rapuano, Tim J. van Hartevelt, Gustavo Deco, Paul Expert, Aart H. Schene, Morten L. Kringelbach, Henricus G. Ruhé

    Neurobiological models to explain vulnerability of major depressive disorder (MDD) are scarce and previous functional magnetic resonance imaging studies mostly examined “static” functional connectivity (FC). Knowing that FC constantly evolves over time, it becomes important to assess how FC dynamically differs in remitted‐MDD patients vulnerable for new depressive episodes. Using a recently developed method to examine dynamic FC, we characterized re‐emerging FC states during rest in 51 antidepressant‐free MDD patients at high risk of recurrence (≥2 previous episodes), and 35 healthy controls. We examined differences in occurrence, duration, and switching profiles of FC states after neutral and sad mood induction. Remitted MDD patients showed a decreased probability of an FC state (p < 0.005) consisting of an extensive network connecting frontal areas—important for cognitive control—with default mode network, striatum, and salience areas, involved in emotional and self‐referential processing. Even when this FC state was observed in patients, it lasted shorter (p < 0.005) and was less likely to switch to a smaller prefrontal–striatum network (p < 0.005). Differences between patients and controls decreased after sad mood induction. Further, the duration of this FC state increased in remitted patients after sad mood induction but not in controls (p < 0.05). Our findings suggest reduced ability of remitted‐MDD patients, in neutral mood, to access a clinically relevant control network involved in the interplay between externally and internally oriented attention. When recovering from sad mood, remitted recurrent MDD appears to employ a compensatory mechanism to access this FC state. This study provides a novel neurobiological profile of MDD vulnerability.


  • Open Access

    Decreased functional connectivity of the insula within the salience network as an indicator for prospective insufficient response to antidepressants

    by H. Geugies, E.M. Opmeer, J.B.C. Marsman, C.A. Figueroa, M.J. van Tol, L. Schmaal, N.J.A. van der Wee, A. Aleman, B.W.J.H. Penninx, D.J. Veltman, et al.